Mutar Study, Phase Ii, Open-Label Study of Erlotinib (E) Treatment in Patients (Pts) with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (Mnsclc) Who Present Activating Mutations (Mut plus ) in the Tyrosine Kinase (Tki) Domain of the Epidermal Growth Factor Receptor (Egfr), Assessed the Efficacy of 1L in Portuguese Pts with Mnsclc Egfr Mut

AuthID
 P-00M-3DR
6
Author(s)
Barata, F
·
Queiroga, H
·
Teixeira, E
·
Parente, B
·
Soares, M
Tipo de Documento
Letter
Year published
2016
Publicado
in REVISTA PORTUGUESA DE PNEUMOLOGIA, ISSN: 0873-2159
Volume: 22, Número: 5, Páginas: 287-288 (2)
Indexing
Wos®
Google Scholar®
Publication Identifiers
Wos: WOS:000383412700008
Source Identifiers
ISSN: 0873-2159
Export Publication Metadata
Lista Marked
 Adicionar à lista Marked
Citações
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

CORE Conference
No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Info
At this moment we don't have any links to full text documens.

Um espaço para investigadores e suas Instituições

Links Úteis

Ajuda

© 2026 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service